Listed

Chefs' Warehouse, Inc.: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 10, 2023 and accepted by EDGAR at May 10, 2023, 16:27 ET.

Share

Management's discussion and analysis

As filed, 13,404 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided as a supplement to the accompanying condensed consolidated financial statements and footnotes to help provide an understanding of our financial condition, changes in our financial condition and results of operations. The following discussion should be read in conjunction with information included in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2023. Unless otherwise indicated, the terms “Company”, “Chefs’ Warehouse”, “we”, “us” and “our” refer to The Chefs’ Warehouse, Inc. and its subsidiaries.

Business Overview

We are a premier distributor of specialty foods in the leading culinary markets in the United States and the Middle East. We offer more than 55,000 stock-keeping units (“SKUs”), ranging from high-quality specialty foods and ingredients to basic ingredients and staples and center-of-the-plate proteins. We serve more than 40,000 customer locations, primarily located in our 23 geographic markets across the United States, Middle East and Canada, and the majority of our customers are independent restaurants and fine dining establishments. We also sell certain of our products directly to consumers through our Allen Brothers and “Shop Like a Chef” retail channels.

Recent Acquisitions

On March 20, 2023, pursuant to an asset purchase agreement, we acquired substantially all of the assets of Hardie’s F&V, LLC (“Hardie’s Fresh Foods”), a specialty produce distributor with operations in Texas. The initial purchase price was approximately $38.0 million, paid in cash at closing and is subject to customary working capital adjustments. We will also pay additional contingent consideration, if earned, in the form of an earn-out amount which could total $10.0 million over a two-year period.

During the thirteen weeks ended March 31, 2023 , the Company completed two other acquisitions for an aggregate purchase price of approximately $14.4 million, consisting of $12.2 million paid in cash at closing, subject to customer working capital adjustments, and $2.2 million of deferred payments. The Company will also pay additional contingent consideration, if earned, in the form of earn-out amounts which could total $2.0 million in the aggregate.

RESULTS OF OPERATIONS

Thirteen Weeks Ended March 31, 2023 March 25, 2022
Net sales $719,645 $512,103
Cost of sales 549,937 394,590
Gross profit 169,708 117,513
Selling, general and administrative expenses 156,137 110,086
Other operating expenses, net 1,672 1,163
Operating income 11,899 6,264
Interest expense 10,006 4,365
Income before income taxes 1,893 1,899
Provision for income tax expense 492 514
Net income $1,401 $1,385

Management evaluates the results of operations and cash flows using a variety of key performance indicators, including net sales compared to prior periods and internal forecasts, costs of our products and results of our cost-control initiatives, and use of operating cash. These indicators are discussed throughout the “Results of Operations” and “Liquidity and Capital Resources” sections of this MD&A.

Thirteen Weeks Ended March 31, 2023 Compared to Thirteen Weeks Ended March 25, 2022

Net Sales

2023 2022 $ Change % Change
Net sales $719,645 $512,103 $207,542 40.5%

Organic growth contributed $87.9 million, or 17.1%, to sales growth and the remaining sales growth of $119.7 million, or 23.4%, resulted from acquisitions. Organic case count increased approximately 16.8% in our specialty category. In addition, specialty unique customers and placements increased 21.2% and 18.7%, respectively, compared to the prior year period. Organic pounds sold in our center-of-the-plate category increased 14.4% compared to the prior year. Estimated inflation was 5.5% in our specialty category and 3.2% in our center-of-the-plate category compared to the prior year period.

Gross Profit

2023 2022 $ Change % Change
Gross profit $169,708 $117,513 $52,195 44.4%
Gross profit margin 23.6% 22.9%

Gross profit dollars increased primarily as a result of increased sales and price inflation. Gross profit margin increased approximately 64 basis points. Gross profit margins increased 65 basis points in the Company’s specialty category and decreased 68 basis points in the Company’s center-of-the-plate category. Estimated inflation was 5.5% in the Company’s specialty category and 3.2% in the center-of-the-plate category compared to the prior year period. Specialty margins increased primarily due to changes in product mix. Margin rates in the center-of-the-plate category decreased due to higher inflationary impacts of certain products during the first quarter of fiscal 2023.

Selling, General and Administrative Expenses

2023 2022 $ Change % Change
Selling, general and administrative expenses $156,137 $110,086 $46,051 41.8%
Percentage of net sales 21.7% 21.5%

The increase in selling, general and administrative expenses was primarily due to higher costs associated with compensation and benefits, facilities costs, and distribution costs to support sales growth. Our ratio of selling, general and administrative expenses to net sales was relatively consistent with the prior year quarter.

Other Operating Expenses, Net

2023 2022 $ Change % Change
Other operating expenses, net $1,672 $1,163 $509 43.8%

The increase in net other operating expenses was primarily due to higher third-party deal costs incurred in connection with business acquisitions.

Interest Expense

2023 2022 $ Change % Change
Interest expense $10,006 $4,365 $5,641 129.2%

Interest expense increased primarily driven by higher principal amounts of outstanding debt due to our 2028 convertible notes issued on December 13, 2022, our term loan refinancing on August 23, 2022, an increase in amounts drawn on our asset-based loan facility and higher rates of interest charged on the variable rate portion of our outstanding debt.

Provision for Income Taxes

2023 2022 $ Change % Change
Provision for income tax expense $492 $514 $(22) (4.3)%
Effective tax rate 26.0% 27.1%

The lower effective tax rate for the thirteen weeks ended March 31, 2023 was primarily driven by a greater mix of foreign earnings that are subject to tax rates below the US statutory rate of 21%.

LIQUIDITY AND CAPITAL RESOURCES

We finance our day-to-day operations and growth primarily with cash flows from operations, borrowings under our senior secured credit facilities and other indebtedness, operating leases, trade payables and equity financing.

Indebtedness

The following table presents selected financial information on our indebtedness (in thousands):

March 31, 2023 December 30, 2022
Senior secured term loan $298,500 $299,250
Total convertible debt 331,184 333,184
Borrowings outstanding on asset-based loan facility and revolving credit facilities 42,217 42,217
Finance leases and other financing obligations 14,913 11,331
Total $686,814 $685,982

As of March 31, 2023, we have various floating- and fixed-rate debt instruments with varying maturities for an aggregate principal amount of $671.9 million.

Liquidity

The following table presents selected financial information on liquidity (in thousands):

March 31, 2023 December 30, 2022
Cash and cash equivalents $91,742 $158,800
Working capital, excluding cash and cash equivalents 300,871 278,315
Availability under asset-based loan facility 135,830 135,827
Total $528,443 $572,942

We expect our capital expenditures, excluding cash paid for acquisitions, for fiscal 2023 will be approximately $50.0 million to $60.0 million. We believe our existing balances of cash and cash equivalents, working capital and the availability under our asset-based loan facility, are sufficient to satisfy our working capital needs, capital expenditures, debt service and other liquidity requirements associated with our current operations over the next 12 months.

Cash Flows

The following table presents selected financial information on cash flows (in thousands):

Thirteen Weeks Ended March 31, 2023 March 25, 2022
Net income $1,401 $1,385
Non-cash charges $20,995 $14,271
Changes in working capital $(24,657) $(5,373)
Net cash (used in) provided by operating activities $(2,261) $10,283
Net cash used in investing activities $(59,633) $(42,206)
Net cash used in financing activities $(5,141) $(3,851)

Net cash used in operations was $2.3 million for the thirteen weeks ended March 31, 2023 compared to net cash provided by operating activities of $10.3 million for the thirteen weeks ended March 25, 2022. The decrease in cash provided by operating activities was primarily due to the working capital growth of $19.3 million versus the prior year period which was driven by a strategic decision to pull forward inventory purchases of certain product categories during the first quarter of fiscal 2023. We expect our inventory levels to normalize during the remainder of the year. The increase in cash used for working capital growth was partially offset by increased net income, net of non-cash charges, in the current year of $22.4 million compared to $15.7 million in the prior year period. This increase is driven by higher depreciation and amortization expenses, stock-based compensation expenses and a release in our provision for doubtful accounts in the prior year quarter related to the pandemic recovery which did not recur in the current period.

Net cash used in investing activities was $59.6 million for the thirteen weeks ended March 31, 2023, driven by capital expenditures of $8.7 million and $50.9 million in cash paid for acquisitions.

Net cash used in financing activities was $5.1 million for the thirteen weeks ended March 31, 2023 driven by $3.4 million of payments of debt and other financing obligations, including finance leases, and $1.8 million paid for shares surrendered to pay tax withholding related to the vesting of equity incentive plan awards.

Seasonality

Excluding our direct-to-consumer business, we generally do not experience any material seasonality. However, our sales and operating results may vary from quarter to quarter due to factors such as changes in our operating expenses, management’s ability to execute our operating and growth strategies, personnel changes, demand for our products, supply shortages, weather patterns and general economic conditions.

Our direct-to-consumer business is subject to seasonal fluctuations, with direct-to-consumer center-of-the-plate protein sales typically higher during the holiday season in our fourth quarter; accordingly, a disproportionate amount of operating cash flows from this portion of our business is generated by our direct-to-consumer business in the fourth quarter of our fiscal year. Despite a significant portion of these sales occurring in the fourth quarter, there are operating expenses, principally advertising and promotional expenses, throughout the year.

Inflation

Our profitability is dependent on, among other things, our ability to anticipate and react to changes in the costs of key operating resources, including food and other raw materials, labor, energy and other supplies and services. Substantial increases in costs and expenses could impact our operating results to the extent that such increases cannot be passed along to our customers. The impact of inflation and deflation on food, labor, energy and occupancy costs can significantly affect the profitability of our operations.

Critical Accounting Policies and Estimates

The preparation of the Company’s condensed consolidated financial statements requires it to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The SEC has defined critical accounting policies and estimates as those that are both most important to the portrayal of the Company’s financial condition and results and require its most difficult, complex or subjective judgments or estimates. Based on this definition, we believe our critical accounting policies and estimates include the following: (i) determining our allowance for doubtful accounts, (ii) inventory valuation, with regard to determining inventory balance adjustments for excess and obsolete inventory, (iii) business combinations, (iv) valuing goodwill and intangible assets, (v) self-insurance reserves, (vi) accounting for income taxes and (vii) contingent earn-out liabilities. Our critical accounting policies and estimates are described in the Form 10-K filed with the SEC on February 28, 2023.

Market risk

As filed, 389 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Interest Rate Risk

Our exposure to interest rate market risk relates primarily to our long-term debt. As of March 31, 2023, we had aggregate indebtedness outstanding of $340.7 million that bore interest at variable rates. A 100 basis point increase in market interest rates would decrease our after tax earnings by approximately $2.5 million per annum, holding other variables constant.

Controls and procedures

As filed, 950 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of March 31, 2023.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 351 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended December 30, 2022 filed with the SEC on February 28, 2023. In addition to the information contained herein, you should consider the risk factors disclosed in our Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-12-31 to 2023-03-31$719.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-12-31 to 2023-03-31$549.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-12-31 to 2023-03-31$169.7mus-gaap:GrossProfit
Selling, general and administrative3 months2022-12-31 to 2023-03-31$156.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-12-31 to 2023-03-31$11.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-12-31 to 2023-03-31$10.0mus-gaap:InterestExpense
Income tax3 months2022-12-31 to 2023-03-31$492.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-12-31 to 2023-03-31$1.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-12-31 to 2023-03-31$0.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-12-31 to 2023-03-31$0.04us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-12-31 to 2023-03-3138,161,269 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-12-31 to 2023-03-31−$2.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-12-31 to 2023-03-31$8.7mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2023-03-31$91.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$696.8mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$1.55bnus-gaap:Assets
Current liabilitiesAt period end2023-03-31$304.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$1.15bnus-gaap:Liabilities
Long-term debtAt period end2023-03-31$654.4mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-03-31$13.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-03-31$406.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001517175-23-000010. Last ingested by Listed: Nov 15, 2026, 01:17 ET. Listed shows no prices and gives no investment advice.